AID Partners GP Holdings Limited cancelled the acquisition of Alpha Mark Limited from ACT Co., Ltd..
January 31, 2021
Share
AID Partners GP Holdings Limited agreed to acquire Alpha Mark Limited from ACT Co., Ltd. (KOSDAQ:A138360) for KRW 17.5 billion on January 31, 2020. Under the terms, AID Partners will acquire 1 share in Alpha Mark and ACT will have no ownership in Alpha. If the payment is not paid in cash even after the extended deadline, ACT may seize all of the security shares. If the security seizes the securities, it will be regarded as fulfillment of trading value and termination of transaction. Alpha Mark reported total assets of KRW 96.5 billion. The transaction was approved by the ACT board on January 31, 2020. The transaction is scheduled to close on February 3, 2020. Banseok Accounting Corporation acted as accountant for ACT.
AID Partners GP Holdings Limited cancelled the acquisition of Alpha Mark Limited from ACT Co., Ltd. (KOSDAQ:A138360) on January 31, 2021.
Hyupjin Co Ltd, formerly ACT Co Ltd is a Korea-based company engaged in the manufacture and sale of raw materials of cosmetics. The Company provides bioconversion technology products, encapsulated products, natural extracts, synthetic products and others. Its products include Aquatouch L, which is made of glycerin, dimethicone, water and lecithin; Silkytouch L, which is made of water, dimethicone, glycerin, palmitoyl inulin, behenyl alcohol and 1,2 hexanediol; Phytoact Reliefer, which is made of phaseolus radiates seed extract, avena sativa meal extract, ethyhexylglycerin and others, as well as PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir and Actosome Deage, among others. It also provides electronic materials.
HYUPJIN CO., LTD. 